Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial,Journal of Child and Adolescent Psychopharmacology

当前位置： X-MOL 学术 › J. Child Adolesc. Psychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial
Journal of Child and Adolescent Psychopharmacology ( IF 1.5 ) Pub Date : 2022-04-18 , DOI: 10.1089/cap.2021.0104
Takuya Saito ₁ , Mitsuhiro Ishida ₂ , Atsushi Nishiyori ₂ , Toshimitsu Ochiai ₃ , Hideaki Katagiri ₄ , Hideo Matsumoto ₅

Affiliation

Objective: The goal of this study was to evaluate the efficacy and safety of duloxetine in children and adolescents (9–17 years of age) with major depressive disorder (MDD) in Japan.

中文翻译：